scispace - formally typeset
M

Miguel A. Gutierrez

Researcher at University of California, Los Angeles

Publications -  7
Citations -  541

Miguel A. Gutierrez is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Phospholipase & Innate immune system. The author has an hindex of 6, co-authored 7 publications receiving 518 citations.

Papers
More filters
Journal ArticleDOI

MyD88 Mediates Neutrophil Recruitment Initiated by IL-1R but Not TLR2 Activation in Immunity against Staphylococcus aureus

TL;DR: It is found that lesions of S. aureus-infected MyD88- and IL-1R-deficient mice were substantially larger with higher bacterial counts compared with wild-type mice, suggesting that resident skin cells utilize IL- 1R/MyD88 signaling to promote neutrophil recruitment.
Journal ArticleDOI

Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy.

TL;DR: The accumulation of host-derived oxidized phospholipids in L-lep lesions is strikingly similar to observations in atherosclerosis, which suggests that the link between host lipid metabolism and innate immunity contributes to the pathogenesis of both microbial infection and metabolic disease.
Journal ArticleDOI

Generalized Lichenoid Reaction from Tattoo

TL;DR: This work presents the fourth case of a generalized lichenoid reaction to a tattoo, and the risks of treating tattoo reactions with lasers will also be discussed.
Journal ArticleDOI

Doxycycline-induced pseudotumor cerebri.

TL;DR: This case illustrates that despite the rarity of doxycycline-induced PTC, patients and physicians should be aware of this possibility and in the setting of new-onset headaches or visual changes, early ophthalmologic examination for papilledema is recommended for early diagnosis.
Journal ArticleDOI

New World cutaneous leishmaniasis: current challenges in diagnosis and parenteral treatment.

TL;DR: 3 cases of New World CL that were either initially misdiagnosed or faced significant delays in therapy are presented and the optimal approach by which to confirm New WorldCL is discussed.